aTyr Pharma Announces First Quarter 2020 Results and Provides Corporate Update on ATYR1923 Clinical Trials in Pulmonary Sarcoidosis and COVID-19
Go back to aTyr Pharma Announces First Quarter 2020 Results and Provides Corporate Update on ATYR1923 Clinical Trials in Pulmonary Sarcoidosis and COVID-19| Life Technologies Corporation (NASDAQ: LIFE) | Delayed: 35.85 -0.15 (0.42%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $36.00 | 52 Week High | $10.93 | |||
| Open | $35.73 | 52 Week Low | $2.48 | |||
| Day High | $36.82 | P/E | 13.23 | |||
| Day Low | $35.20 | EPS | $2.71 | |||
| Volume | 120,941 | |||||
